Mady Hornig, MD, professor of Epidemiology at Columbia University's Mailman School of Public Health. Credit: Columbia University's Mailman School of Public Health
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction—frequently described by patients as "brain fog"—as well as new hope for improvements in diagnosis and treatment.
In the study published in Molecular Psychiatry, Mady Hornig, MD, and colleagues used immunoassay testing methods to measure the levels of 51 immune biomarkers called cytokines in the cerebrospinal fluid of 32 people with ME/CFS for an average of seven years, 40 with multiple sclerosis, and 19 non-diseased controls. The researchers found that levels of most cytokines, including the inflammatory immune molecule, interleukin 1, were depressed in individuals with ME/CFS compared with the other two groups, matching what was seen in the blood study in patients who had the disease for more than three years. One cytokine—eotaxin—was elevated in the ME/CFS and MS groups, but not in the control group.
"We now know that the same changes to the immune system that we recently reported in the blood of people with ME/CFS with long-standing disease are also present in the central nervous system," says Dr. Hornig, professor of Epidemiology and director of translational research at the Center for Infection and Immunity at the Mailman School. "These immune findings may contribute to symptoms in both the peripheral parts of the body and the brain, from muscle weakness to brain fog."
Implications for Diagnosis and Treatment
"Diagnosis of ME/CFS is now based on clinical criteria. Our findings offer the hope of objective diagnostic tests for disease as well as the potential for therapies that correct the imbalance in cytokine levels seen in people with ME/CFS at different stages of their disease," adds W. Ian Lipkin, MD, John Snow Professor of Epidemiology and director of the Center for Infection and Immunity. There is precedent for use of human monoclonal antibodies that regulate the immune response in a wide range of disorders from rheumatoid arthritis to multiple sclerosis. However, the researchers note, additional work will be needed to assess the safety and efficacy of this approach.
Explore further: Scientists discover robust evidence that chronic fatigue syndrome is a biological illness
Medical Xpress on facebook
Related Stories
Scientists discover robust evidence that chronic fatigue syndrome is a biological illness
Researchers at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health identified distinct immune changes in patients diagnosed with chronic fatigue syndrome, known medically as myalgic ...
New IOM report identifies five symptoms to diagnose chronic fatigue syndrome
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—commonly referred to as ME/CFS—is a legitimate, serious, and complex systemic disease that frequently and dramatically limits the activities of affected individuals, ...
Toward a clearer diagnosis of chronic fatigue syndrome
Researchers at the RIKEN Center for Life Science Technologies, in collaboration with Osaka City University and Kansai University of Welfare Sciences, have used functional PET imaging to show that levels of ...
Brain neuroinflammation seen in chronic fatigue syndrome
(HealthDay)—Neuroinflammation markers are elevated in the brains of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients compared to healthy controls, according to a study published online ...
Panel asks: What defines chronic fatigue syndrome?
(HealthDay)—Chronic fatigue syndrome is about to get a new clinical definition, with the hope that it will help physicians better diagnose people afflicted with the mysterious and complex disorder.
Recommended for you
Electroconvulsive therapy changes key areas of the human brain that play a role in memory, emotion
Although scientists know that depression affects the brain, they don't know why some people respond to treatment while others do not.
Publication bias and 'spin' raise questions about drugs for anxiety disorders
A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders.
What is the best measure of depression severity in adolescents?
At present the key symptom for diagnosing major depressive disorder (MDD) in adolescents is irritability. However a new study has found that the severity of anhedonia (the inability to gain pleasure from ...
Classroom behaviour and dyslexia research
Bournemouth University lecturer Dr Julie Kirkby is investigating the significance of copying and note-taking in the classroom and how it affects the learning of Dyslexic children.
We all feel disgust but why do some of us turn it on ourselves?
Disgust is a universal emotion – we all get disgusted by things, just as we all experience other "basic" emotions, such as happiness and sadness. Disgust has many functions. It protects us from products ...
Study finds vast regional differences in personality within the UK
How exactly do we become the people we are? A study published earlier this week found that there are vast regional differences in personality within the UK. ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
Mady Hornig, MD, professor of Epidemiology at Columbia University's Mailman School of Public Health. Credit: Columbia University's Mailman School of Public Health
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction—frequently described by patients as "brain fog"—as well as new hope for improvements in diagnosis and treatment.
In the study published in Molecular Psychiatry, Mady Hornig, MD, and colleagues used immunoassay testing methods to measure the levels of 51 immune biomarkers called cytokines in the cerebrospinal fluid of 32 people with ME/CFS for an average of seven years, 40 with multiple sclerosis, and 19 non-diseased controls. The researchers found that levels of most cytokines, including the inflammatory immune molecule, interleukin 1, were depressed in individuals with ME/CFS compared with the other two groups, matching what was seen in the blood study in patients who had the disease for more than three years. One cytokine—eotaxin—was elevated in the ME/CFS and MS groups, but not in the control group.
"We now know that the same changes to the immune system that we recently reported in the blood of people with ME/CFS with long-standing disease are also present in the central nervous system," says Dr. Hornig, professor of Epidemiology and director of translational research at the Center for Infection and Immunity at the Mailman School. "These immune findings may contribute to symptoms in both the peripheral parts of the body and the brain, from muscle weakness to brain fog."
Implications for Diagnosis and Treatment
"Diagnosis of ME/CFS is now based on clinical criteria. Our findings offer the hope of objective diagnostic tests for disease as well as the potential for therapies that correct the imbalance in cytokine levels seen in people with ME/CFS at different stages of their disease," adds W. Ian Lipkin, MD, John Snow Professor of Epidemiology and director of the Center for Infection and Immunity. There is precedent for use of human monoclonal antibodies that regulate the immune response in a wide range of disorders from rheumatoid arthritis to multiple sclerosis. However, the researchers note, additional work will be needed to assess the safety and efficacy of this approach.
Explore further: Scientists discover robust evidence that chronic fatigue syndrome is a biological illness
Medical Xpress on facebook
Related Stories
Scientists discover robust evidence that chronic fatigue syndrome is a biological illness
Researchers at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health identified distinct immune changes in patients diagnosed with chronic fatigue syndrome, known medically as myalgic ...
New IOM report identifies five symptoms to diagnose chronic fatigue syndrome
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—commonly referred to as ME/CFS—is a legitimate, serious, and complex systemic disease that frequently and dramatically limits the activities of affected individuals, ...
Toward a clearer diagnosis of chronic fatigue syndrome
Researchers at the RIKEN Center for Life Science Technologies, in collaboration with Osaka City University and Kansai University of Welfare Sciences, have used functional PET imaging to show that levels of ...
Brain neuroinflammation seen in chronic fatigue syndrome
(HealthDay)—Neuroinflammation markers are elevated in the brains of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients compared to healthy controls, according to a study published online ...
Panel asks: What defines chronic fatigue syndrome?
(HealthDay)—Chronic fatigue syndrome is about to get a new clinical definition, with the hope that it will help physicians better diagnose people afflicted with the mysterious and complex disorder.
Recommended for you
Electroconvulsive therapy changes key areas of the human brain that play a role in memory, emotion
Although scientists know that depression affects the brain, they don't know why some people respond to treatment while others do not.
Publication bias and 'spin' raise questions about drugs for anxiety disorders
A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders.
What is the best measure of depression severity in adolescents?
At present the key symptom for diagnosing major depressive disorder (MDD) in adolescents is irritability. However a new study has found that the severity of anhedonia (the inability to gain pleasure from ...
Classroom behaviour and dyslexia research
Bournemouth University lecturer Dr Julie Kirkby is investigating the significance of copying and note-taking in the classroom and how it affects the learning of Dyslexic children.
We all feel disgust but why do some of us turn it on ourselves?
Disgust is a universal emotion – we all get disgusted by things, just as we all experience other "basic" emotions, such as happiness and sadness. Disgust has many functions. It protects us from products ...
Study finds vast regional differences in personality within the UK
How exactly do we become the people we are? A study published earlier this week found that there are vast regional differences in personality within the UK. ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment